Method for treating fibromyalgia

摘要

Provided is a therapeutic or prophylactic agent for generalized pain syndrome, for which no cause and therapies have been established. A therapeutic or prophylactic agent for generalized pain syndrome containing an LPA1 antagonist or autotaxin-inhibiting substance as an active ingredient. The pharmaceutical is preferably administered to the central nervous system. The generalized pain syndrome is preferably fibromyalgia, chronic fatigue syndrome or hypersensitivity colitis.

主权项

1. A method of treating fibromyalgia in a subject comprising administering to the subject an effective amount of a low-molecular weight compound that binds to LPA1 to inhibit signaling, thereby treating fibromyalgia in the subject.